VS-5584, a Novel and Highly Selective PI3K/mTOR Kinase Inhibitor for the Treatment of Cancer

Dysregulation of the PI3K/mTOR pathway, either through amplifications, deletions, or as a direct result of mutations, has been closely linked to the development and progression of a wide range of cancers. Moreover, this pathway activation is a poor prognostic marker for many tumor types and confers...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hart, Stefan, Novotny-Diermayr, Veronica, Goh, Kee Chuan, Williams, Meredith, Tan, Yong Cheng, Ong, Lai Chun, Cheong, Albert, Ng, Bee Kheng, Amalini, Chithra, Madan, Babita, Nagaraj, Harish, Jayaraman, Ramesh, Pasha, Khalid M., Ethirajulu, Kantharaj, Chng, Wee Joo, Mustafa, Nurulhuda, Goh, Boon Cher, Benes, Cyril, McDermott, Ultan, Garnett, Mathew, Dymock, Brian, Wood, Jeanette M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3588144/
https://ncbi.nlm.nih.gov/pubmed/23270925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-12-0466
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados